By Matt Fair (November 13, 2017, 8:58 PM EST) -- In a decision implicating hundreds of cases pending in a mass tort program in Philadelphia, a Pennsylvania appeals court ruled Monday that two boys who allegedly grew breasts after taking the Johnson & Johnson antipsychotic Risperdal had waited too long to sue over their injuries.
The state's Superior Court found that the two plaintiffs in the mass tort program, which now includes some 6,400 cases, should have known about the potential link between their abnormal breast growth and the powerful antipsychotic when a label for the medication was updated in October 2006 to reflect heightened incidences of the side effect....
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!